Efficacy of Cognitive Behavioral Therapy–Based Digital Therapeutics for Substance Use Disorder: Protocol for a Randomized Controlled Trial
JMIR Research Protocols · 07.08.2026 · 15 · e85458-e85458
DOI: 10.2196/85458 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, online erschienen am 07.08.2026. Verfasst von Yong Chan Jeong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Hallym University, Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea. Hauptthemen laut MEDLINE: Substance-Related Disorders, Cognitive Behavioral Therapy. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
Illicit drug use has been rapidly increasing in South Korea, particularly among individuals in their 20s, contributing to a growing burden of substance use disorder (SUD). However, treatment infrastructure remains limited. Nationwide, only a small number of inpatient treatment hospitals are available, and treatment capacity in the Seoul metropolitan area is insufficient to meet growing demand. In addition, community-based addiction services are scarce, creating barriers to continuous care. Digital therapeutics (DTx) have emerged as a promising approach to improve treatment accessibility and continuity of care. In particular, cognitive behavioral therapy (CBT)–based DTx such as RESET-O, developed in the United States and authorized by the US Food and Drug Administration, have demonstrated clinical benefits in supporting addiction recovery. Building on this concept, our team developed D-STOP, a CBT-based DTx intervention designed to support individuals with SUD in the Korean clinical context.
Objective
This study aims to evaluate the efficacy of D-STOP as an adjunctive DTx intervention for patients with SUD.
Methods
This study is a randomized controlled clinical trial designed to evaluate the efficacy of D-STOP in individuals diagnosed with SUD. Following an initial screening assessment, 118 participants meeting the diagnostic criteria will be enrolled. Participants will be recruited from psychiatry departments at addiction treatment and clinical care institutions in Chuncheon, Seoul, Daegu, and Changnyeong, South Korea. During the 12-week intervention period, the experimental group will receive D-STOP in addition to treatment as usual, whereas the control group will receive treatment as usual alone. D-STOP delivers structured CBT-based modules and motivational enhancement interventions through a digital platform. During scheduled study visits, participants will also receive therapeutic feedback from psychiatrists or trained study staff. The primary end point is the abstinence success rate during weeks 9 to 12 of treatment. Logistic regression analysis will be used to estimate treatment effects and evaluate superiority compared with the control group.
Results
The study protocol was approved by the institutional review board of Hallym University Chuncheon Sacred Heart Hospital on April 14, 2025. Funding began on April 1, 2023. Data collection started on August 4, 2025, and is expected to be completed by November 30, 2026. As of March 6, 2026, a total of 65 participants have been enrolled. An interim analysis of the primary efficacy outcome has been conducted based on the data available at the time of analysis; however, statistical significance has not been established due to the limited sample size. The final analysis is expected to be published in April 2027.
Conclusions
DTx have the potential to expand access to evidence-based addiction treatment in resource-constrained settings. This study will provide clinical evidence on the efficacy and feasibility of D-STOP as a digital treatment support tool for patients with SUD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Science, Hallym University, Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea.
- Department of Electronic and Telecommunications Engineering, UBIPLUS Co Ltd, Chuncheon, Republic of Korea.
- Department of Physics, Seoul National University, Seoul, South Korea.
- Department of Biomedical Engineering, Catholic University of Daegu, Daegu, South Korea.
- Department of Psychiatry, Daedong Hospital, Daegu, Republic of Korea.
- Department of Psychiatry, Bugok National Hospital, Changnyeong-Gun, Republic of Korea.
ORCID-Profile: Yong Chan Jeong, Byoung-Kwon Lee, Jae-Kyoung Shin, Ye-Jin Jang, Do Hoon Kwon, Tae Kyung Lee, Boung Chul Lee, Haemin Seo, Ha Yeong Choi, Sang-Kyu Lee
Zitieren
APA
Jeong, Y. C., Lee, B. K., Shin, J. K., Jang, Y. J., Kwon, D. H., Lee, T. K., Lee, B. C., Seo, H., Choi, H. Y., & Lee, S. K. (2026). Efficacy of Cognitive Behavioral Therapy–Based Digital Therapeutics for Substance Use Disorder: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 15, e85458-e85458. https://doi.org/10.2196/85458
Vancouver
Jeong YC, Lee BK, Shin JK, Jang YJ, Kwon DH, Lee TK, et al. Efficacy of Cognitive Behavioral Therapy–Based Digital Therapeutics for Substance Use Disorder: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e85458-e85458. doi:10.2196/85458
BibTeX
@article{Jeong2026,
author = {Jeong, Yong Chan and Lee, Byoung-Kwon and Shin, Jae-Kyoung and Jang, Ye-Jin and Kwon, Do Hoon and Lee, Tae Kyung and Lee, Boung Chul and Seo, Haemin and Choi, Ha Yeong and Lee, Sang-Kyu},
title = {Efficacy of Cognitive Behavioral Therapy–Based Digital Therapeutics for Substance Use Disorder: Protocol for a Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2026},
volume = {15},
pages = {e85458--e85458},
doi = {10.2196/85458}
}
EUVIMED